Results 81 to 90 of about 201 (100)

Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects

Journal of Clinical Pharmacology, 2018
Sreeraj Macha, Karsten Menzel, Carolyn R Cho   +2 more
exaly  

Pharmacokinetics and safety of the anti‐human cytomegalovirus drug letermovir in subjects with hepatic impairment

British Journal of Clinical Pharmacology, 2017
Dirk Kropeit, Holger Zimmermann
exaly  

Antifungals/letermovir/tacrolimus

Reactions Weekly, 2022
openaire   +1 more source

Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir

Antiviral Research, 2015
Holger Zimmermann, Peter Lischka
exaly  

Letermovir/Tacrolimus interaction

Reactions Weekly, 2023
openaire   +1 more source

Letermovir for the management of cytomegalovirus infection

Expert Opinion on Investigational Drugs, 2017
Lyndsey J Bowman, Jennifer I Melaragno
exaly  

Everolimus/letermovir/steroids

Reactions Weekly, 2023
openaire   +1 more source

Letermovir/valganciclovir

Reactions Weekly, 2018
openaire   +1 more source

Foscarnet/letermovir

Reactions Weekly, 2019
openaire   +1 more source

Letermovir/prednisolone

Reactions Weekly, 2019
openaire   +1 more source